Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSIP1 | O75475 | 1/20 | 0.45 |
| ▸ | PARL | Q9H300 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CCR5 | P51681 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.37 |
| ▸ | HTR6 | P50406 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | XBP1 | P17861 | 1/20 | 0.35 |
| ▸ | MPI | P34949 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11133553 | 0.90 | TRPA1 (0.42) | PSIP1PARLMAPK1CCR5SMN1; SMN2 | |
| SCHEMBL8460017 | 0.87 | ALDH1A1 (0.51) | PSIP1MAPK1SMN1; SMN2TDP1ALDH1A1 | |
| SCHEMBL11361031 | 0.86 | CA12 (0.50) | PSIP1PARLSMN1; SMN2TDP1HSD11B1 | |
| SCHEMBL16044692 | 0.85 | PSIP1 (0.45) | PSIP1PARLCCR5SMN1; SMN2TDP1 | |
| SCHEMBL780731 | 0.84 | GAA (0.42) | SMN1; SMN2ALDH1A1 | |
| SCHEMBL5668420 | 0.84 | PSIP1 (0.44) | PSIP1PARLMAPK1CCR5SMN1; SMN2 | |
| SCHEMBL28099707 | 0.82 | PSIP1 (0.42) | PSIP1PARLCCR5SMN1; SMN2TDP1 | |
| SCHEMBL28506829 | 0.81 | ALDH1A1 (0.46) | MAPK1SMN1; SMN2TDP1ALDH1A1MAPT | |
| SCHEMBL776370 | 0.81 | RAB9A (0.47) | PSIP1PARLSMN1; SMN2TDP1HTR6 | |
| SCHEMBL16046201 | 0.81 | PSIP1 (0.43) | PSIP1PARLMAPK1SMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2297081-B1 | 1-(2-ETHYL-BUTYL)-CYCLOHEXANECARBOXYLIC ACID ESTER AS AN INTERMEDIATE IN THE PREPARATION OF PHARMACEUTICALLY ACTIVE AMIDES | HOFFMANN LA ROCHE (CH) | 2017-03-08 | — | — | EP | disclosed |
| EP-2274278-B1 | NEW PROCESS FOR THE PREPARATIION OF CYCLOHEXANECARBOXYLIC ACID DERICATIVES | HOFFMANN LA ROCHE (CH) | 2016-08-17 | — | — | EP | disclosed |
| US-20160200672-A1 | NEW PROCESS | HOFFMANN-LA ROCHE INC. | 2016-07-14 | — | — | US | disclosed |
| CN-101981001-B | Prepare the new method of naphthenic acid derivant | 弗·哈夫曼-拉罗切有限公司 | 2016-06-08 | — | — | CN | disclosed |
| US-20150361034-A1 | NEW PROCESS | HOFFMANN-LA ROCHE INC. | 2015-12-17 | — | — | US | disclosed |
| EP-2616433-B1 | PROCESS FOR PREPARING A CYCLOHEXANECARBONITRILE DERIVATIVE | HOFFMANN LA ROCHE (CH) | 2015-12-09 | — | — | EP | disclosed |
| US-20140336403-A1 | PROCESS | F. HOFFMANN-LA ROCHE AG (CH) | 2014-11-13 | — | — | US | disclosed |
| CN-101952236-B | New process for the preparation of cyclohexanecarboxylic acid derivatives via the corresponding cyclohexanecarboxamide derivative | HOFFMANN LA ROCHE | 2014-07-02 | — | — | CN | disclosed |
| CN-102066311-B | 1-(2-ethyl-butyl) -cyclohexanecarboxylic acid ester as an intermediate in the preparation of pharmaceutically active amides | HOFFMANN LA ROCHE | 2014-07-02 | — | — | CN | disclosed |
| EP-2274264-B1 | NEW PROCESS FOR THE PREPARATION OF CYCLOHEXANECARBOXYLIC ACID DERIVATIVES VIA THE CORRESPONDING CYCLOHEXANECARBOXAMIDE DERIVATIVE | HOFFMANN LA ROCHE (CH) | 2014-02-12 | — | — | EP | disclosed |
| CN-101573319-A | Process for preparing 1- (2-ethyl-butyl) -cyclohexanecarboxylic acid | HOFFMANN LA ROCHE (CH) | 2009-11-04 | — | — | CN | disclosed |
| US-20090253927-A1 | PROCESS FOR CYCLOHEXANECARBOXYLIC ACID DERIVATIVES | HOFFMANN-LA ROCHE, INC. | 2009-10-08 | — | — | US | disclosed |
| US-20090253928-A1 | PREPARATION FOR A CYCLOHEXANECARBOXYLIC ACID DERIVATIVE AND INTERMEDIATES | HOFFMANN-LA ROCHE, INC. | 2009-10-08 | — | — | US | disclosed |
| WO-2009121788-A1 | NEW PROCESS FOR THE PREPARATIION OF CYCLOHEXANECARBOXYLIC ACID DERICATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2009-10-08 | — | — | WO | disclosed |
| WO-2009121789-A1 | NEW PROCESS FOR THE PREPARATION OF CYCLOHEXANECARBOXYLIC ACID DERIVATIVES VIA THE CORRESPONDING CYCLOHEXANECARBOXAMIDE DERIVATIVE | F. HOFFMANN-LA ROCHE AG (CH) | 2009-10-08 | — | — | WO | disclosed |
| US-20090240080-A1 | PROCESS FOR THE PREPARATION OF CETP(1) | HOFFMANN URSULA | 2009-09-24 | — | — | US | disclosed |
| EP-2094636-A1 | PROCESS FOR PREPARING 1-(2-ETHYL-BUTYL)-CYCLOHEXANECARBOXYLIC ACID | F. Hoffmann-Roche AG (CH) | 2009-09-02 | — | — | EP | disclosed |
| US-20080154059-A1 | PROCESS FOR THE PREPARATION OF CETP(1) | HOFFMANN-LA ROCHE INC. | 2008-06-26 | — | — | US | disclosed |
| WO-2008074677-A1 | PROCESS FOR PREPARING 1- (2-ETHYL-BUTYL) -CYCLOHEXANECARBOXYLIC ACID | F. HOFFMANN-LA ROCHE AG (CH) | 2008-06-26 | — | — | WO | disclosed |
| EP-1935867-A1 | Process for preparing 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid | F. HOFFMANN-LA ROCHE AG (CH) | 2008-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160200672-A1 | NEW PROCESS | CYP4A11, UGT1A1, CYP11B1 | PSIP1 961/4885PARL 4602/4885MAPK1 918/4885 |
| US-20080154059-A1 | PROCESS FOR THE PREPARATION OF CETP(1) | CETP, CES1, CPA1 | PSIP1 743/4885PARL 4026/4885MAPK1 3431/4885 |
| US-20150361034-A1 | NEW PROCESS | CYP4A11, UGT1A1, CYP11B1 | PSIP1 961/4885PARL 4602/4885MAPK1 918/4885 |
| US-20090240080-A1 | PROCESS FOR THE PREPARATION OF CETP(1) | CETP, CES1, CPA1 | PSIP1 743/4885PARL 4026/4885MAPK1 3431/4885 |
| US-20090253927-A1 | PROCESS FOR CYCLOHEXANECARBOXYLIC ACID DERIVATIVES | CYP2C9, CYP51A1, CYP2B6 | PSIP1 3117/4885PARL 4690/4885MAPK1 1308/4885 |
| US-20090253928-A1 | PREPARATION FOR A CYCLOHEXANECARBOXYLIC ACID DERIVATIVE AND INTERMEDIATES | CYP2A13, CYP1A1, CYP2C19 | PSIP1 2885/4885PARL 4634/4885MAPK1 1233/4885 |
| US-20140336403-A1 | PROCESS | UGT1A1, CYP3A7, CYP2F1 | PSIP1 936/4885PARL 4467/4885MAPK1 1141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.